移植市场规模、份额及成长分析（依产品类型、应用、最终用途及地区）－2025-2032 年产业预测

2023 年全球移植市场规模价值为 154.7 亿美元，预计将从 2024 年的 168.5 亿美元成长到 2032 年的 333.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.9%。

全球移植市场预计将经历显着增长，主要原因是人口老化和生活方式改变导致器官衰竭和慢性病发病率上升。手术技术的改进、免疫抑制疗法的进步以及组织工程的创新显着提高了移植成功率，从而推动了需求。然而，该领域面临的挑战包括移植手术的复杂性、对专门护理的需求以及移植前后护理的高成本所带来的经济负担。儘管存在这些障碍，但透过机器灌注器官保存和免疫抑制剂的改进等技术，仍具有市场开发潜力。提高意识和政府齐心协力促进器官捐赠对于解决器官短缺问题、扩大移植服务以及最终改善患者预后至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

移植市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概览
• 纸巾产品
• 免疫抑制剂
• 储存解决方案

移植市场规模：按应用和复合年增长率（2025-2032）

• 市场概览
• 器官移植
• 组织移植

移植市场规模：依最终用途及复合年增长率（2025-2032）

• 市场概览
• 医院
• 移植中心
• 其他的

移植市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• AbbVie Inc.（USA）
• BioLife Solutions（USA）
• Medtronic（USA）
• Arthrex, Inc.（USA）
• Zimmer Biomet（USA）
• 21st Century Medicine（USA）
• Novartis AG（Switzerland）
• Stryker（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Veloxis Pharmaceuticals, Inc.（USA）
• TransMedics Inc.（USA）
• Hoffmann-La Roche Ltd.（Switzerland）
• Astellas Pharma Inc.（Japan）
• Preservation Solutions, Inc.（USA）
• OrganOx Limited（UK）
• Terumo Corporation（Japan）
• Transonic（USA）
• Sanofi（France）
• Pfizer Inc.（USA）
• CareDx, Inc.（USA）

结论和建议

Global Transplantation Market size was valued at USD 15.47 billion in 2023 and is poised to grow from USD 16.85 billion in 2024 to USD 33.32 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global transplantation market is poised for significant growth, driven primarily by the rising incidence of organ failure and chronic diseases, fueled by aging populations and lifestyle changes. Enhanced surgical techniques, advanced immunosuppressive therapies, and innovations in tissue engineering have markedly improved transplant success rates, boosting demand. However, the sector faces challenges, including the complexity of transplant procedures, specialized care requirements, and the financial burden associated with high costs of pre- and post-transplant care. Despite these hurdles, the market holds potential for advancement through technology, such as machine perfusion for organ preservation and the development of improved immunosuppressive drugs. Increased awareness and collaborative government efforts to promote organ donation are essential to address shortages and expand transplantation services, ultimately enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segments Analysis

Global Transplantation Market is segmented by Product Type, Application, End-Use and region. Based on Product Type, the market is segmented into Tissue Products, Immunosuppressive Drugs and Preservation Solutions. Based on Application, the market is segmented into Organ Transplantation and Tissue Transplantation. Based on End-Use, the market is segmented into Hospitals, Transplant Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplantation Market

The increasing prevalence of chronic diseases, including end-stage renal failure, liver cirrhosis, heart failure, and respiratory ailments, is driving significant growth in the global transplantation market. Specifically, the surge in diabetes cases and its associated complications has intensified the need for kidney and pancreas transplants. As more individuals require these vital organ transplants to improve their quality of life and overcome debilitating health conditions, the demand for transplantation services continues to rise. This trend highlights the critical role that healthcare providers and organizations play in addressing the urgent need for organ donations and transplantation solutions worldwide.

Restraints in the Global Transplantation Market

The global transplantation market faces several constraints primarily due to the high costs associated with organ transplantation. Expenses encompass pre-transplant evaluations, surgical procedures, post-operative care, and ongoing immunosuppressive medication, creating substantial financial strains for patients, healthcare systems, and insurance providers alike. Additionally, inadequate insurance coverage and restrictive reimbursement policies surrounding transplant-related services further diminish the affordability and accessibility of these essential procedures. As a result, many individuals may struggle to receive necessary transplants, which can significantly hinder the overall growth and development of the transplantation market on a worldwide scale.

Market Trends of the Global Transplantation Market

The global transplantation market is witnessing a notable trend towards precision medicine, reflecting a heightened emphasis on personalized transplant therapies. This approach leverages individual genetic profiles, immunological compatibility, and specific disease characteristics to enhance treatment efficacy. The incorporation of advanced diagnostics and biomarkers facilitates tailored immunosuppressive strategies, leading to improved patient outcomes and reduced complications. As healthcare providers increasingly utilize genetic testing, the demand for customized transplant protocols is expected to rise, driving innovation and fueling market growth. This shift towards precision medicine underscores the commitment to optimize transplantation success rates and enhance quality of life for patients worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Transplantation Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

Global Transplantation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Organ Transplantation
• Tissue Transplantation

Global Transplantation Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Transplant Centers
• Others

Global Transplantation Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-Use)
  • US
  • Canada
• Europe (Product Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 21st Century Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veloxis Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransMedics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Preservation Solutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrganOx Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transonic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations